MedChunk
Medically reviewed

AMH After Menopause: Causes and When to See a Doctor

Learn why AMH levels are usually undetectable after menopause, what a detectable or high result may mean, possible causes, and when to see a doctor.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 12 min read

AMH (anti-Müllerian hormone) levels normally fall to very low or undetectable levels after menopause because the ovaries no longer have the supply of developing egg follicles that produce this hormone. If an AMH test shows a measurable or unexpectedly high level after menopause, a doctor may investigate the result to check for an ovarian condition, including certain rare ovarian tumors. However, one abnormal result does not establish a diagnosis.

What happens to AMH levels after menopause?

AMH is a hormone produced by cells in the small follicles of the ovaries. Before menopause, its level provides information about ovarian reserve, which refers to the remaining supply of eggs in the ovaries.

As a person gets older, the number of available eggs decreases. AMH levels generally decline along with this reduction. By menopause, AMH levels usually become undetectable.

According to MedlinePlus, AMH levels decrease as the egg supply declines and drop to zero at menopause. This is why AMH is mainly used for reproductive health assessments before menopause rather than as a routine measure of ovarian function afterward.

It is important to understand that an AMH result after menopause has a different meaning from the same result in a younger woman. Measurements used to assess fertility or ovarian reserve are not generally useful for interpreting ovarian function after natural menopause.

What can cause detectable or high AMH after menopause?

A measurable AMH result after menopause deserves attention, particularly when the level is clearly elevated or increases over time. Several factors may be relevant, depending on a person's medical history and the reason the test was performed.

1. Granulosa cell tumor of the ovary

One important condition doctors may consider when AMH is unexpectedly high after menopause is a granulosa cell tumor. This is an uncommon type of ovarian cancer that develops from cells associated with the ovarian follicles.

Some granulosa cell tumors produce AMH, making the hormone useful as a tumor marker. Doctors may measure it when investigating an ovarian mass or monitoring someone who has already been diagnosed with this type of tumor.

According to Cleveland Clinic, AMH testing may help healthcare professionals assess whether an ovarian mass is a granulosa cell tumor. It may also be used to monitor treatment response and check for a possible recurrence.

A granulosa cell tumor is rare, and an elevated AMH result does not mean that someone has ovarian cancer. Imaging and other clinical investigations are needed before a diagnosis can be established.

2. Other ovarian conditions associated with high AMH

Certain ovarian conditions can be associated with higher-than-expected AMH levels. One example is polycystic ovary syndrome (PCOS), which is associated with increased AMH in some people.

However, PCOS is not a reason to automatically explain a newly detectable AMH result after menopause. A healthcare professional will consider whether there is a previous PCOS diagnosis, the person's reproductive history, and other clinical findings before interpreting the result.

MedlinePlus explains that AMH testing can help identify and monitor certain ovarian conditions associated with high AMH, including PCOS and some types of ovarian cancer. The hormone level alone cannot establish which condition, if any, is responsible.

3. History of an ovarian tumor

Someone who has previously been diagnosed with a granulosa cell tumor may continue to have AMH measurements as part of follow-up care.

In this situation, the result is interpreted differently from an unexpected finding in someone without a previous tumor diagnosis. A rising AMH level may raise concern about residual or recurrent disease, particularly when AMH was elevated when the original tumor was diagnosed.

The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) describes AMH as one of the blood markers that may be used alongside inhibin B, imaging, and clinical examinations when evaluating and monitoring granulosa cell tumors.

Its patient information on granulosa cell tumors also emphasizes the importance of long-term follow-up because these tumors can sometimes return after treatment.

4. Differences between laboratory testing methods

Not all laboratories use identical equipment or testing methods to measure AMH. Small differences in reported results can occur between laboratories.

For this reason, a slightly detectable result should not automatically be interpreted as evidence of an ovarian problem. The laboratory method, measurement unit, reference information, and previous results all matter.

When a result seems unexpected, the doctor may review the original report and consider whether repeating the test or arranging further investigations would be useful.

Does high AMH after menopause always mean ovarian cancer?

No. An elevated AMH result does not automatically mean ovarian cancer. Although some ovarian tumors, particularly granulosa cell tumors, can produce AMH, the test is not sufficient to diagnose cancer on its own.

The significance of a high result depends on several factors, including:

  • The actual AMH concentration and the laboratory method used.
  • Whether the result is slightly detectable or substantially elevated.
  • Whether previous AMH measurements were available for comparison.
  • Any history of ovarian conditions or ovarian tumors.
  • The presence of abdominal, pelvic, or other concerning symptoms.
  • Findings from physical examinations and pelvic imaging.

A doctor may recommend additional testing when the result suggests that an ovarian condition needs investigation. The purpose is to identify the explanation rather than assume the most serious possibility.

What symptoms should you watch for after menopause?

AMH changes themselves do not usually cause noticeable symptoms. However, some ovarian conditions associated with abnormal hormone production may have symptoms that deserve medical attention.

Examples of symptoms that should be discussed with a healthcare professional include:

  • Persistent abdominal swelling or bloating.
  • Ongoing pain or pressure in the lower abdomen or pelvic area.
  • Feeling full sooner than usual when eating.
  • Unexplained changes in appetite.
  • Frequent or urgent urination.
  • Persistent constipation or changes in bowel habits.
  • Unexplained weight loss.
  • Unusual vaginal bleeding after menopause.

These symptoms can have many causes and do not necessarily indicate an ovarian tumor. However, persistent or unusual changes should not be ignored.

The Centers for Disease Control and Prevention (CDC) advises seeking medical attention for unusual vaginal bleeding after menopause. It also recommends medical evaluation when other possible ovarian cancer symptoms continue for two weeks or longer.

When should you see a doctor about AMH after menopause?

Arrange an appointment with your doctor or gynecologist if an AMH test shows a detectable or elevated result after menopause, particularly when the result is unexpected or increasing.

It is especially important to arrange an evaluation in the following situations:

  • An unexpectedly high AMH result: A measurable level that is higher than expected after menopause may need further investigation.
  • A rising AMH level: An increase between tests deserves review, especially when there is a history of an ovarian tumor.
  • Previous granulosa cell tumor: Follow the recommended monitoring schedule, even when there are no noticeable symptoms.
  • Persistent abdominal or pelvic symptoms: New or ongoing bloating, pain, pressure, or changes in appetite should be discussed with a doctor.
  • Bleeding after menopause: Any vaginal bleeding after menopause should be assessed promptly, even if it is light or occurs only once.

The NHS guidance on ovarian cancer symptoms recommends medical assessment when symptoms are persistent, becoming more frequent, or getting worse. Although these symptoms are often caused by conditions other than cancer, checking them can help identify the underlying reason.

How do doctors investigate an abnormal AMH result?

The evaluation depends on the AMH level, medical history, symptoms, and any previous ovarian diagnoses. A doctor may recommend several steps to understand why the result is detectable or elevated.

Review of the blood test

The doctor will usually review the AMH concentration, units, laboratory reference information, and the reason for testing. Previous results may also be compared to identify whether the level has remained stable or changed.

If the result is unexpected, repeating the blood test may be considered to confirm the finding.

Physical and pelvic examination

A healthcare professional may ask about abdominal discomfort, bloating, changes in appetite, vaginal bleeding, previous ovarian conditions, and family medical history.

A physical examination may also be performed to check for abdominal or pelvic abnormalities.

Pelvic ultrasound

A pelvic ultrasound can help examine the ovaries and surrounding structures. A transvaginal ultrasound uses a small ultrasound probe placed inside the vagina to obtain detailed images of the pelvic organs. An abdominal ultrasound may also be used.

These scans can help identify an ovarian mass or other structural changes that may require further assessment.

Additional blood tests

Depending on the suspected condition, doctors may request additional blood tests. These may include inhibin B and estradiol when investigating a possible granulosa cell tumor.

CA-125 may also be measured when an ovarian mass or another type of ovarian cancer is being investigated. However, CA-125 is not specific to cancer, and its result must be interpreted alongside imaging and other clinical findings.

What if AMH is detectable but you have no symptoms?

Having no symptoms is reassuring, but it does not explain why AMH is measurable after menopause. Some ovarian tumors can be present without noticeable symptoms, particularly in their earlier stages.

At the same time, a detectable result does not automatically indicate a serious condition. The next step depends on the actual concentration, laboratory method, previous medical history, and whether other investigations show any abnormalities.

Discuss the result with the healthcare professional who requested the test. They can decide whether monitoring, repeat testing, or imaging is appropriate.

Can AMH be used to monitor ovarian health after menopause?

AMH is not generally used as a routine test to assess ovarian reserve after natural menopause. By this stage, ovarian egg supplies have declined, and the hormone is usually no longer detectable.

However, AMH can have a specific role in monitoring certain ovarian tumors, particularly granulosa cell tumors, when it was elevated at the time of diagnosis.

Therefore, the usefulness of AMH depends on the clinical purpose of the test. A result used for tumor monitoring should be interpreted differently from a test originally ordered to assess fertility or reproductive aging.

What should you do if your AMH result is high after menopause?

The most useful first step is to review the result with a gynecologist or the doctor who ordered the test. Take the complete laboratory report, including the AMH value, units, and reference information, along with any previous results.

Explain how long it has been since menopause, whether your ovaries have been removed, whether you have a history of PCOS or an ovarian tumor, and whether you have noticed any new symptoms.

Do not assume that an elevated result means cancer, but do not dismiss an unexpected finding without appropriate medical review. A careful assessment can help determine whether additional blood tests, ultrasound imaging, or specialist evaluation is needed.

Frequently Asked Questions

Common questions about AMH levels, unexpected test results, and ovarian health after menopause.

1. Should AMH be zero after menopause?

AMH levels normally decline to very low or undetectable levels after menopause because the supply of developing ovarian follicles has been depleted. A measurable result should be interpreted using the laboratory method and individual medical history rather than a single universal cutoff.

2. Can high AMH after menopause indicate ovarian cancer?

Yes, certain ovarian tumors, particularly granulosa cell tumors, can produce AMH. However, a high AMH result alone cannot diagnose ovarian cancer. Doctors may use pelvic ultrasound, other tumor markers, and clinical examinations to investigate the cause.

3. Can AMH increase again after menopause?

AMH normally remains very low or undetectable after menopause. An unexpected increase deserves medical review. Certain ovarian tumors can produce AMH, especially granulosa cell tumors, and rising levels may also be important in people being monitored after treatment for these tumors.

4. Should I repeat an AMH test if it is detectable after menopause?

A doctor may recommend repeating the test when the result is unexpected or does not fit the clinical picture. The decision depends on the original value, laboratory method, medical history, and whether additional investigations are needed.

5. Does postmenopausal bleeding have anything to do with AMH?

Postmenopausal bleeding is not a direct measure of AMH levels. However, unusual bleeding after menopause requires prompt medical assessment because it can have several causes, including conditions affecting the uterus or ovaries. A healthcare professional can determine which examinations are appropriate.

Citations

  1. MedlinePlus – Anti-Müllerian Hormone Test
  2. Cleveland Clinic – Anti-Mullerian Hormone Test: Purpose, Levels and Results
  3. International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) – Granulosa Cell Tumor
  4. Centers for Disease Control and Prevention (CDC) – Symptoms of Ovarian Cancer
  5. National Health Service (NHS) – Ovarian Cancer: Symptoms
Share this article